Elizabeth Trehu MD

Elizabeth Trehu, M.D., brings to Jounce more than 25 years of clinical experience, including nearly 15 years in the biotech industry-leading translational and integrated hematology and oncology drug development. Dr. Trehu joins Jounce from Promedior, Inc., where she served as the chief medical officer. In this role, she was responsible for clinical development, clinical operations, regulatory affairs, quality assurance, and program management, and led the creation and implementation of clinical development plans for Promedior’s lead product candidate. Prior to Promedior, Dr. Trehu served as vice president, oncology product development and medical affairs for Infinity Pharmaceuticals, and earlier, held various leadership positions at Genzyme Corporation, including vice president and general manager of hematology for Genzyme’s transplant oncology group.